Uszko-Lencer Nicole H M K, Frankenstein Lutz, Spruit Martijn A, Maeder Micha T, Gutmann Marc, Muzzarelli Stefano, Osswald Stefan, Pfisterer Matthias E, Zugck Christian, Brunner-La Rocca Hans-Peter
Department of Cardiology, CARIM; Maastricht University Medical Centre + (MUMC+), Maastricht, The Netherlands; Department of Research & Education, CIRO, Centre of Expertise for Chronic Organ Failure, Horn, The Netherlands.
Cardiologist, Department of Cardiology, Angiology, Pulmonology, University of Heidelberg, Heidelberg, Germany.
Int J Cardiol. 2017 Jan 15;227:901-907. doi: 10.1016/j.ijcard.2016.11.122. Epub 2016 Nov 9.
Prediction of events in chronic heart failure (CHF) patients is still difficult and available scores are often complex to calculate. Therefore, we developed and validated a simple-to-use, multidimensional prognostic index for such patients.
A theoretical model was developed based on known prognostic factors of CHF that are easily obtainable: Body mass index (B), Age (A), Resting systolic blood pressure (R), Dyspnea (D), N-termInal pro brain natriuretic peptide (NT-proBNP) (I), Cockroft-Gault equation to estimate glomerular filtration rate (C), resting Heart rate (H), and Exercise performance using the 6-min walk test (E) (the BARDICHE-index). Scores were given for all components and added, the sum ranging from 1 (lowest value) to 25 points (maximal value), with estimated risk being highest in patients with highest scores. Scores were categorized into three groups: a low (≤8 points); medium (9-16 points), or high (>16 points) BARDICHE-score. The model was validated in a data set of 1811 patients from two prospective CHF-cohorts (median follow-up 887days). The primary outcome was 5-year all-cause survival. Secondary outcomes were 5-year survival without all-cause hospitalization and 5-year survival without CHF-related hospitalization.
There were significant differences between BARDICHE-risk groups for mortality (hazard ratio=3.63 per BARDICHE-group, 95%-CI 3.10-4.25), mortality or all-cause hospitalization (HR=2.00 per BARDICHE-group, 95%-CI 1.83-2.19), and mortality or CHF-related hospitalization (HR=3.43 per BARDICHE-group, 95%-CI 3.01-3.92; all P<10-50). Outcome was predicted independently of left ventricular ejection fraction (LVEF) and gender.
The BARDICHE-index is a simple multidimensional prognostic tool for patients with CHF, independently of LVEF.
预测慢性心力衰竭(CHF)患者的事件仍然困难,且现有的评分计算通常复杂。因此,我们为这类患者开发并验证了一种易于使用的多维预后指数。
基于CHF已知的易于获得的预后因素开发了一个理论模型:体重指数(B)、年龄(A)、静息收缩压(R)、呼吸困难(D)、N末端脑钠肽前体(NT-proBNP)(I)、用Cockcroft-Gault方程估算的肾小球滤过率(C)、静息心率(H)以及使用6分钟步行试验评估的运动能力(E)(BARDICHE指数)。对所有组成部分给出分数并相加,总和范围为1分(最低值)至25分(最大值),分数最高的患者估计风险最高。分数分为三组:低(≤8分);中(9 - 16分)或高(>16分)BARDICHE评分。该模型在来自两个前瞻性CHF队列的1811例患者的数据集中进行了验证(中位随访887天)。主要结局是5年全因生存率。次要结局是5年无全因住院生存率和5年无CHF相关住院生存率。
BARDICHE风险组在死亡率(风险比 = 每BARDICHE组3.63,95%置信区间3.10 - 4.25)、死亡率或全因住院率(HR = 每BARDICHE组2.00,95%置信区间1.83 - 2.19)以及死亡率或CHF相关住院率(HR = 每BARDICHE组3.43,95%置信区间3.01 - 3.92;所有P < 10⁻⁵⁰)方面存在显著差异。结局的预测独立于左心室射血分数(LVEF)和性别。
BARDICHE指数是一种用于CHF患者的简单多维预后工具,独立于LVEF。